Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 32.

Lehmann, K; Eshmuminov, D; Bauerfeind, P; Gubler, C; Veit-Haibach, P; Weber, A; Abdul-Rahman, H; Fischer, M; Reiner, C; Schneider, P M (2017). (18)FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma. European Journal of Surgical Oncology, 43(1):196-202.

Meerwein, C M; Sekine, T; Veit-Haibach, P; Bredell, M G; Huber, G F; Huellner, M W (2017). Multi-slice SPECT/CT vs. lymphoscintigraphy and intraoperative gamma ray probe for sentinel node mapping in HNSCC. European Archives of Oto-Rhino-Laryngology, 274(3):1633-1642.

Bogowicz, M; Riesterer, O; Bundschuh, R A; Veit-Haibach, P; Hüllner, M; Studer, G; Stieb, S; Glatz, S; Pruschy, M; Guckenberger, M; Tanadini-Lang, S (2016). Stability of radiomic features in CT perfusion maps. Physics in Medicine and Biology, 61(24):8736-8749.

Bailey, D L; Pichler, B J; et al; Veit-Haibach, P (2016). Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany. Molecular Imaging and Biology, 18(5):637-650.

de Galiza Barbosa, F; Delso, G; Ter Voert, E E G W; Huellner, M W; Herrmann, K; Veit-Haibach, P (2016). Multi-technique hybrid imaging in PET/CT and PET/MR: what does the future hold? Clinical Radiology, 71(7):660-672.

de Galiza Barbosa, F; Delso, G; Zeimpekis, K G; Ter Voert, Edwin E G W; Hüllner, M; Stolzmann, P; Veit-Haibach, P (2015). Evaluation and clinical quantification of neoplastic lesions and physiological structures in TOF-PET/MRI and non-TOF/MRI - a pilot study. The quarterly journal of nuclear medicine and molecular imaging:Epub ahead of print.

Scheyerer, M J; Hüllner, M W; Pietsch, C; Veit-Haibach, P; Werner, C M L (2014). Implant-bone interface of sacroiliac joint fusion using iFuse implant system. ISRN Minimally Invasive Surgery, 2014:571014.

Veit-Haibach, P; Schmid, D; Strobel, K; Soyka, J D; Schaefer, N G; Haerle, S K; Huber, G F; Studer, G; Seifert, Burkhardt; Hany, T F (2013). Combined PET/CT-perfusion in patients with head and neck cancers. European Radiology, 23(1):163-173.

Delso, G; Wollenweber, S; Lonn, A; Wiesinger, F; Veit-Haibach, P (2013). MR-driven metal artifact reduction in PET/CT. Physics in medicine and biology, 58(7):2267-2280.

Appenzeller, P; Mader, C; Huellner, M W; Schmidt, D; Schmid, D; Boss, A; von Schulthess, G; Veit-Haibach, P (2013). PET/CT versus body coil PET/MRI: how low can you go? Insights into Imaging, 4(4):481-490.

Huellner, M W; Strobel, K; Hug, U; von Wartburg, U; Veit-Haibach, P (2012). SPECT/CT in der Handgelenkdiagnostik. Der Radiologe, 52(7):621-628.

Schaefer, N G; Veit-Haibach, P; Soyka, J D; Steinert, H C; Stahel, R A (2012). Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): Value of 18F-FDG-PET/CT. European Journal of Radiology, 81(1):e19-e25.

Huellner, M W; Hennedige, T P; Winterhalder, R; Zander, T; Venkatesh, S K; Yong, W P; Soo, R A; Seifert, Burkhardt; Treumann, T C; Strobel, K; Veit-Haibach, P (2012). Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer. Cancer Imaging, 12(1):212-224.

Veit-Haibach, P; Schiesser, M; Soyka, J; Strobel, K; Schaefer, N G; Hesselmann, R; Clavien, P A; Hany, T F (2011). Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component. European Radiology, 21(2):256-264.

Veit-Haibach, P; Treyer, V; Strobel, K; Soyka, J D; Husmann, L; Schaefer, N G; Tschopp, A; Hany, T F (2010). Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdominal Imaging, 35(5):528-536.

Petrausch, U; Samaras, P; Haile, S R; Veit-Haibach, P; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schäefer, N G (2010). Risk adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first line therapy. Annals of Oncology, 21(8):1694-1698.

Petrausch, U; Samaras, P; Veit-Haibach, P; Tschopp, A; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schaefer, N G (2010). Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? Annals of Oncology, 21(5):1053-1057.

Veit-Haibach, P; Schaefer, N G; Steinert, H C; Soyka, J D; Seifert, B; Stahel, R A (2010). Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma. Lung Cancer, 67(3):311-317.

Soyka, J D; Strobel, K; Veit-Haibach, P; Schaefer, N G; Schmid, D T; Tschopp, A; Hany, T F (2010). Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine. Journal of Nuclear Medicine, 51(4):507-510.

Schiesser, M; Veit-Haibach, P; Muller, M K; Weber, M; Bauerfeind, P; Hany, T; Clavien, P A (2010). Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours. British Journal of Surgery, 97(5):691-697.

Husmann, L; Tatsugami, F; Aepli, U; Herzog, B A; Valenta, I; Veit-Haibach, P; Buechel, R R; Pazhenkottil, A P; Gaemperli, O; Burkhard, N; Wyss, C A; Kaufmann, P A (2009). Prevalence of noncardiac findings on low dose 64-slice computed tomography used for attenuation correction in myocardial perfusion imaging with SPECT. International Journal of Cardiovascular Imaging, 25(8):859-865.

Husmann, L; Herzog, B A; Gaemperli, O; Tatsugami, F; Burkhard, N; Valenta, I; Veit-Haibach, P; Wyss, M T; Landmesser, U; Kaufmann, P A (2009). Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography/computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering vs. retrospective gating. European Heart Journal, 30(5):600-607.

Strobel, K; Haerle, S K; Stoeckli, S J; Schrank, M; Soyka, J D; Veit-Haibach, P; Hany, T F (2009). Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with 18F-FDG-PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 36(6):919-927.

Strobel, K; Bode, B; Dummer, R; Veit-Haibach, P; Fischer, D R; Imhof, L; Goldinger, S; Steinert, H C; von Schulthess, G K (2009). Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. European Journal of Nuclear Medicine and Molecular Imaging, 36(11):1774-1782.

Strobel, K; Dummer, R; Steinert, H C; Baumann Conzett, K; Schad, K; Pérez Lago, M; Soyka, J D; Veit-Haibach, P; Seifert, Burkhardt; Kalff, V (2008). Chemotherapy response assessment in stage IV melanoma patients-comparison of (18)F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B. European Journal of Nuclear Medicine and Molecular Imaging, 35(10):1786-1795.

Husmann, L; Valenta, I; Weber, K; Adda, O; Veit-Haibach, P; Gaemperli, O; Kaufmann, P A (2008). Cardiac fusion imaging with low-dose computed tomography using prospective electrocardiogram gating. Clinical Nuclear Medicine, 33(7):490-491.

Husmann, L; Valenta, I; Veit-Haibach, P; Alkadhi, H; Largiader, T; Kaufmann, P A (2008). Interarterial course of the right coronary artery: assessment with cardiac computed tomography and myocardial perfusion imaging. Clinical Nuclear Medicine, 33(5):335-336.

Soyka, J D; Veit-Haibach, P; Strobel, K; Breitenstein, S; Tschopp, A; Mende, K A; Lago, M P; Hany, T F (2008). Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice? Journal of Nuclear Medicine, 49(3):354-361.

Husmann, L; Valenta, I; Gaemperli, O; Adda, O; Treyer, V; Wyss, C; Veit-Haibach, P; Tatsugami, F; von Schulthess, G K; Kaufmann, P A (2008). Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating. European Heart Journal, 29(2):191-197.

Strobel, K; Heinrich, S; Bhure, U; Soyka, J; Veit-Haibach, P; Pestalozzi, B C; Clavien, P A; Hany, T F (2008). Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. Journal of Nuclear Medicine, 49(9):1408-1413.

Strobel, K; Exner, U E; Stumpe, K D M; Hany, T F; Bode, B; Mende, K; Veit-Haibach, P; von Schulthess, G K; Hodler, J (2008). The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 35(11):2000-2008.

Strobel, K; Schaefer, N; Renner, C; Veit-Haibach, P; Husarik, D; Koma, A; Hany, T (2006). Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients? Annals of Oncology, 18(4):658-664.

This list was generated on Mon Jun 17 10:38:58 2019 CEST.